Siemens Healthineers expands its manufacturing footprint in India with a new production line of Computed Tomography scanners approved under the Government of India’s PLI scheme  

Bengaluru

|2022-04-04
CTaPK facility inauguration

Vivek Kanade Managing Director, Siemens Healthcare Pvt. Ltd. inaugurated the new facility

  • The company inaugurated the new production line at the Bengaluru facility to manufacture Computed Tomography Scanners.

  • The new facility is approved under the Radiology and Imaging Medical devices segment of the Production Linked Incentive (‘PLI’) Scheme by the Government of India (GoI) and the Department of Pharmaceuticals (‘DoP’) 

  • Committed investment of ₹ 91.9 Crores under the PLI scheme for the manufacture of Computed Tomography and Magnetic Resonance Imaging1

Siemens Healthineers announced the expansion of its manufacturing facility in India. In its aim to accelerate the growth of medical devices space in the country, the company has launched its new production line (plant) for Computed Tomography Scanners at its Bengaluru facility.

The Indian Government has identified medical devices as a priority sector for the flagship 'Make in India' program. With an objective to boost domestic manufacturing, and attract large investment in the Medical Device sector, the Department of Pharmaceuticals launched a Production Linked Incentive (PLI) scheme.

The new production line set up by Siemens Healthineers at the Bengaluru factory is approved under the Radiology and Imaging Medical devices segment of the PLI scheme.

Siemens Healthcare Private Limited is one of the approved applicants for the PLI scheme with a committed investment of ₹ 91.9 Crores, for the manufacture of Computed Tomography and Magnetic Resonance Imaging. 

500 Cios F

“We strongly believe in India’s growth story. The investor-friendly initiatives of the Government of India will give a fillip to the Indian Medical Device industry and the healthcare sector at large. Commencing operations of the new CT scanners production line is our first step in culminating the vision into a reality. It will go a long way in our quest of improving access to high-quality healthcare for all.” said, Vivek Kanade, Managing Director, Siemens Healthcare Private Limited.

Augmented by the investor-friendly initiatives of the Government of India (‘GoI’), the PLI scheme has provided the necessary impetus to India’s vision of becoming a global manufacturing hub for medical devices.



1 https://pib.gov.in/PressReleasePage.aspx?PRID=1697065


Download this press release 0.2 MB


Media Contact:

Pranav Patil, Siemens Healthineers, India

Phone: +91-9322297779; Email: pranav.patil@siemens-healthineers.com

Ojashwi Singh, Siemens Healthineers

Mobile: 9958448698; Email: ojashwi.singh@siemens-healthineers.com

Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) pioneers breakthroughs in healthcare. For everyone. Everywhere. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers and its regional companies is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostics, image-guided therapy, in-vivo diagnostics, and innovative cancer care. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care. In fiscal 2021, which ended on September 30, 2021, Siemens Healthineers, which has approximately 66,000 employees worldwide, generated revenue of €18.0 billion and adjusted EBIT of €3.1 billion. Further information is available at www.siemens-healthineers.com.


Siemens Healthineers in India is Great Place to Work® certified, with over 3900 employees across the nation. With a countrywide sales network and round-the-clock service set-up, two manufacturing facilities at Vadodara for Diagnostics and at Bengaluru for Medical Imaging Products, backed by a state-of-the-art R&D center as well as a global software development center at Bengaluru; we are playing a significant role in transforming care delivery in India and supporting healthcare providers across the entire range of patient care – from prevention and early detection to diagnosis and on to treatment and aftercare. Further information is available at www.siemens-healthineers.co.in